Envista closes divestiture of KaVo Treatment Unit & Instrument business for $383M total proceeds

Envista Holdings Corp

Received $317.3M cash at closing; expects total gross proceeds of $383M including $30M earnout and $36.2M adjustments.
Sale includes deferred local closings in Russia, China, and Brazil until asset transfer entities are formed.
Proceeds will fund strategic acquisitions and internal investments in consumables and digital workflow portfolio.
KaVo Imaging business remains with Envista as part of the Equipment & Consumables segment.
Divestiture originally announced September 7, 2021; closed December 31, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.